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We have studied the intracellular trafficking of Sit1
[ferrioxamine B (FOB) transporter] and Enb1 (enterobac-
tin transporter) in Saccharomyces cerevisiae using green
fluorescent protein (GFP) fusion proteins. Enb1 was
constitutively targeted to the plasma membrane. Sit1
was essentially targeted to the vacuolar degradation
pathway when synthesized in the absence of substrate.
Massive plasma membrane sorting of Sit1 was induced
by various siderophore substrates of Sit1, and by cop-
rogen, which is not a substrate of Sit1. Thus, different
siderophore transporters use different regulated traffick-
ing processes. We also studied the fate of Sit1-mediated
internalized siderophores. Ferrioxamine B was recovered
in isolated vacuolar fractions, where it could be detected
spectrophotometrically. Ferrioxamine B coupled to an
inhibitor of mitochondrial protoporphyrinogen oxidase
(acifluorfen) could not reach its target unless the cells
were disrupted, confirming the tight compartmentaliza-
tion of siderophores within cells. Ferrioxamine B coupled
to a fluorescent moiety, FOB-nitrobenz-2-oxa-1,3-diazole,
used as a Sit1-dependent iron source, accumulated in the
vacuolar lumen even in mutants displaying a steady-state
accumulation of Sit1 at the plasma membrane or in
endosomal compartments. Thus, the fates of siderophore
transporters and siderophores diverge early in the traf-
ficking process.
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Iron can enter Saccharomyces cerevisiae cells through
two independent pathways: the siderophore uptake path-
way and the reductive uptake pathway (1,2). Both path-
ways are regulated and respond to iron availability (3; for
a review, see 4). The reductive pathway (5,6) involves the
release of extracellular ferric chelates through reduction at
the cell surface by the inducible plasma membrane reduc-
tases, Fre1p and Fre2p (7,8). A permease-oxidase com-
plex, Ftr1p and Fet3p, is then involved in translocating iron
through the plasma membrane (9,10). The siderophore
pathway mediates iron uptake from siderophores – small
molecules that bind, solubilize and chelate ferric iron in the
environment with high affinity (reviewed in 11). They are
synthesized in a non-ribosomal enzymatic process and
secreted by bacteria and fungi, but not by S. cerevisiae.
The first evidence for the existence of a siderophore
transport system in S. cerevisiae was provided by the
observation that ferrioxamine B (FOB) is efficiently taken
up by cells with defective reductive transport of iron (1).
Four plasma membrane transporters of the multifacilitator
superfamily were later identified as required for the inter-
nalization of several ferrisiderophore complexes (12–15).
Sit1 (YEL065w), which was first identified as a FOB trans-
porter (12), is the least specific for siderophore substrates,
as it can also mediate (with various degrees of efficiency)
the transport of various ferrioxamines and ferrichromes
(FCH) (4,14). Arn1 (YHL040c) mediates the transport of
a specific class of FCHs (14), whereas Taf1 (YHL047c) and
Enb1 (YOL158c) seem to be specifically involved in the
transport of triacetylfusarinine (TAF) (13) and enterobactin
(ENB) (16), respectively.
The intracellular release of iron from siderophores is
probably mediated by special reductases, although this
remains a matter of debate (17). The release of iron from
siderophores is also facilitated by low pH, so special acidic
compartments of the cell, such as vacuoles, may also
be involved. The details of intracellular ferrisiderophore
trafficking, iron release from ferrisiderophores and iron
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in 11). The intracellular fate of siderophores is an important
element in our understanding of the fundamental aspects
of iron metabolism. However, it is also important for
evaluating the potential efficiency of the ‘Trojan Horse’
approach, which involves combining antibiotics or antifun-
gal drugs with siderophores, enhancing drug accumulation
within pathogenic cells (18).
The mechanisms of siderophore transport in S. cerevisiae
have been thoroughly studied, using Arn1 as a model
(17,19,20). It has been shown that Arn1 [carrying a
C-terminal hemagglutinin (HA) tag] is sorted directly from the
Golgi to the endosomal compartment and is not sorted to
the plasma membrane unless the cells are exposed to low
concentrations of FCH (19), which acts on a high-affinity
C-terminal receptor domain of the protein to control intra-
cellular trafficking of the transporter (20). Homologs of
the Arn1 siderophore transporter are present not only in
S. cerevisiae (Sit1, Taf1 and Enb1) but also in many other
fungi, including Candida albicans (21–23), Aspergillus
nidulans (24) and Schizosaccharomyces pombe (25,26). It
is therefore important to determine whether the regulation
of siderophore transporter trafficking described for Arn1 in
S. cerevisiae can be generalized to other siderophore
transporters. We investigated siderophore transporter
trafficking for Sit1 and Enb1, two alternative models. We
used strains bearing green fluorescent protein (GFP)-
tagged versions of the siderophore transporters under
the control of the endogenous promoter or under the
control of a galactose-inducible promoter (pGAL) to explore
potential substrate-induced regulation of the trafficking of
these two siderophore transporters.
We also studied the intracellular fate of the siderophore
FOB in S. cerevisiae, using siderophore analogs. We tried
to develop a simple assay for monitoring siderophore fate,
using canonical FOB or FOB covalently coupled to the
fluorescent moiety nitrobenz-2-oxa-1,3-diazole (NBD). We
also investigated the fate of FOB covalently coupled to
acifluorfen (AF) (Figure 1), a diphenylether that strongly inhibits
protoporphyrinogen oxidase, an essential mitochondrial
enzyme (27), to determine whether it would be feasible
to use AF coupled to siderophores and taken up by yeast
cells as a means of developing new antifungal compounds.
Results
Differences in the behaviour of the four siderophore
transport systems of S. cerevisiae
We checked whether the four siderophore transporters of
S. cerevisiae (Arn1, Enb1, Sit1 and Taf1) displayed similar
intracellular trafficking – sorting from the endosomes to
plasma membrane triggered by a specific substrate. We
first focused on the relative abundance of the various
siderophore transporters and their subcellular distribution
and trafficking as a function of growth conditions. We
used GFP-tagged versions of the siderophore transporters
as an experimental tool. The GFP tag was added to the
Figure 1: Synthesis of conjugate AF-DFOB. Reagents and conditions: (i) AF, pentafluorophenol; DCC, Dicyclohexylcarbodiimide;
THF, tetrafuran and (ii) desferal, 2, Et3N, THF, 508C.
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reported for many plasma membrane transporters with
a cytoplasm-oriented C-terminus (28,29). Cells producing
chromosomal encoded GFP fusion proteins rather than the
original siderophore transporters were used to evaluate
the abundance and location of each transporter. We
checked that the GFP fusion proteins were active by
measuring the rate of iron uptake from FOB, FCH, ENB
and TAF by cells expressing Sit1-GFP, Arn1-GFP, Enb1-
GFP or Taf1-GFP and comparing these rates to those of
cells with unmodified transporters (Figure 2 and S1). We
also monitored the GFP-tagged proteins (and vacuolar free
GFP) microscopically and by Western blotting (Figure 2).
Taf1 is highly specific for TAF, but the Vmax of TAF
transport is lower than that of other siderophores trans-
ported by Sit1 and Arn1 (30), probably because the
concentration of Taf1 is lower than that of other side-
rophore transporters. Accordingly, the Taf1-GFP fusion
protein was not detected by microscopy under any of
the growth conditions tested (not shown). The Sit1-GFP,
Arn1-GFP and Enb1-GFP transporters were detected in
cells grown in both iron-rich (YPD) and iron-deficient
(YPD þ BPS) conditions (Figure 2A), although they were
more abundant under iron-deficient growth conditions,
as shown by fluorescence and western immunoblotting
(Figure 2B).
For Arn1-GFP, a significant fraction of the cleaved GFP
moiety appeared in the lumen of the vacuole (immunode-
tectable protein recovered as free GFP) (Figure 2A,B).
However, under our experimental conditions, and in con-
trast to the results obtained by Yun et al. with an HA-
tagged version of Arn1 (3), we observed two other types
of fluorescent structures: small, intracellular, juxtavacuolar
spots, probably corresponding to endosomes (Figure 2A,
arrows), and the plasma membrane itself, which was
slightly but clearly labelled in some cells, particularly under
inducing conditions (low iron concentration; Figure 2A).
Hence, most Arn1 is sorted to the vacuolar degradation
pathway (19), whereas a small fraction of the protein is
sorted to the plasma membrane and may be easier to
observe by GFP fusion methods than by indirect immuno-
fluorescence. Enb1-GFP was also observed under all
growth conditions (Figure 2A). However, in this case, the
fusion protein was systematically restricted to the plasma
membrane and was not associated with any other com-
partment (Figure 2A). Consistent with the exclusive
plasma membrane sorting of Enb1, we detected no free
GFP by Western blotting (Figure 2B). Some Sit1-GFP was
present in internal compartments (Figure 2A, arrows),
probably endosomes, as confirmed by subcellular fraction-
ation experiments (see below and Figure 4B). Clear vacu-
olar staining was observed and was the most prominent
signal under noninducing conditions (Figure 2A). Under
inducing conditions (low iron concentration), about 90%
of the cells also displayed fluorescence associated with
the plasma membrane (Figure 2A). We assumed that the
GFP fusion proteins behaved similarly to the original
proteins, as uptake activities were not affected by GFP
tagging, as shown for Sit1 in Figure 2C. Thus, the various
siderophore transport systems of S. cerevisiae undergo
different trafficking processes. Under inducing conditions,
Figure 2: Synthesis and location of
chromosomal GFP-tagged siderophore
transporters. A) Cells expressing chromo-
somalGFP-taggedsiderophore transporters
were cultured to midexponential growth
phase in complete medium (YPD) or in
complete medium supplemented with
200 mM BPS for 4 h (YPD þ BPS). Cells
were then examined for GFP fluorescence
and with Nomarski optics. Arrows indicate
round structures possibly corresponding to
endosomes. B) Total protein extracts were
prepared and analysed by Western blotting
for GFP [GFP-tagged transporter (T-GFP)
and free vacuolar GFP] and for Gas1p, as
a loading control. C) We determined FOB
uptake by WT, sit1D and SIT1-GFP cells
cultured to midexponential growth phase
in complete medium supplemented with
200 mM BPS, 100 mM iron citrate (Fe) or
100 mM FOB (means   standard error of
the mean from three experiments). WT,
wild type.
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ments and at the plasma membrane; Enb1 was present
only at the plasma membrane, and Taf1 was undetectable.
We decided to compare the trafficking processes of
detectable transporters with radically different patterns
of behaviour: Sit1 and Enb1.
Fate of newly synthesized Sit1 and Enb1 in the
absence of their respective substrates
For monitoring of the fate of newly synthesized fusion
proteins, genes encoding GFP fusions of Sit1 and Enb1
were inserted into a centromeric (CEN) plasmid (one to
four copies/cell) under the control of the inducible GAL1
promoter. When this ‘Gal system’ was used to induce
transcription in sit1D and enb1D cells, galactose was
generally added for only short periods (60 min) to prevent
the potential mislocalization of proteins because of pro-
longed overproduction. We checked, by Western blotting,
that the level of Sit1 (as GFP fusion) after 1 h of galactose
induction was not significantly different from that when
the corresponding gene was expressed at the original
locus with its endogenous promoter under conditions of
iron deprivation (Figure S2). We monitored the intracellular
fate of Enb1 and Sit1 and their distribution by fluorescence
microscopy after the addition of galactose to cells grown in
raffinose-containing medium. Enb1 was targeted exclu-
sively to the plasma membrane, and newly synthesized
protein was targeted to the bud (Figure 3A). We checked
that the distribution of Enb1 was not affected by the GFP
tag, by constructing a chromosome-encoded version of
ENB1 tagged with GFP at the N-terminus and placed under
the control of the GAL promoter. Plasma membrane target-
ing kinetics were similar for ENB1 tagged with GFP at the
N-terminusandforENB1 tagged at the C-terminus (Figure 3A).
Sit1 initially accumulated in the Golgi apparatus and endo-
somal compartments (Figure S3). It was also found in the
vacuole after 1 h of synthesis, as shown by colocalization
with the vacuolar dye CMAC (Figure 3B). Some plasma
membrane staining was observed, but only after overnight
overexpression (Figure 3B). These locations were con-
firmed by subcellular fractionation experiments followed
by the western immunoblot analysis of several protein
markers (see below and Figure 4B). Thus, newly synthe-
sized Enb1 was targeted directly to the plasma membrane,
whereas newly synthesized Sit1 mostly accumulated in
Golgi/endosomes and in the vacuole.
Substrate-induced regulation of Sit1 but not of
Enb1 trafficking
Before evaluating the effects of various siderophores on
the sorting of Sit1 and Enb1, we determined which side-
rophores were taken up by these transporters, as the
specificity of the transport process may be, to some extent,
strain dependent (30). The overexpression of SIT1-GFP in
sit1D cells did not increase the uptake of coprogen (CG),
TAF or ferric citrate. Instead, it resulted in a massive in-
crease in FOB uptake rate. Ferrichrome and ferricrocin (FC)
uptake rates were also significantly increased (Table 1).
ENB1-GFP overexpression doubled the rate of ENB uptake
but had no influence on the uptake of any other iron source
(Table 1). Thus, FOB, FCH and FC can reasonably be
Figure 3: Kinetics of Enb1 and Sit1 tar-
geting to the plasma membrane and/or
in endosomes. A) Enb1D cells trans-
formed with pGAL-ENB1-GFP, GAL-GFP-
ENB1 cells and B) sit1D cells transformed
with pGAL-SIT1-GFP were cultured to mid-
exponentialgrowth phasewith raffinoseas
the carbon source. Galactose was then
added and cells were examined for GFP
fluorescenceevery30 minfor2 h andafter
incubation overnight. Sit1D cells trans-
formed with pGAL-SIT1-GFP, grown in
the presence of galactose for 1 h, were
stained with CMAC (Materials and Meth-
ods) to visualize the vacuolar lumen (B).
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probably the only substrate of Enb1, although this trans-
porter seems to be much less efficient than Sit1, as we
previously reported (31). We studied the effect of FOB,
the most specific substrate of Sit1, on Sit1-GFP traffick-
ing. Sit1-GFP expression was induced in cells grown over-
night on a raffinose-based medium, by incubation with
galactose for 60 min in the presence (þFOB) or absence
( FOB) of FOB (10 mM). The distribution of Sit1-GFP was
then checked by fluorescence (Figure 4A). In parallel, ali-
quots of induced cells were disrupted with glass beads,
fractionated on sucrose gradients, and the fractions were
analysed by western immunobloting for the presence of
Sit1-GFP and markers of several compartments (Figure 4B).
After 1 h ofsynthesis inthe absenceof FOB, Sit1-GFP was
detected mostly as small dots ( FOB, Figure 4A). These
dots may correspond to the Golgi apparatus/endosomal
compartments, consistent with cofractionation of internal
Sit1-GFP with the Golgi marker Vps10 and the endosomal
markers Pep12 and Vps55 (Figure 4B). Faint vacuolar
staining was also observed. Accordingly, free GFP was
detected by western immunoblotting in light fractions,
corresponding to both cytosolic proteins [phosphoglycer-
ate kinase (PGK)] and soluble vacuolar lumen proteins
released by cell disruption with glass beads (Figure 4B).
After prolonged growth in the presence of FOB and the
preparation of intact vacuoles from protoplasts, free GFP
was found to colocalize with the vacuolar membrane-
boundVph1 (see Figure 8B).No Sit1-GFPplasmamembrane
staining was observed in these experimental conditions,
but we cannot exclude the possibility that Sit1-GFP was
present in trace amounts at the plasma membrane, as
a faint signal was detected in subcellular fractions colo-
calising with the plasma membrane marker plasma mem-
brane ATPase 1 (Pma1) (Figure 4B). Moreover, the main
Sit1-GFP signal detected corresponded to fraction 10 of
the sucrose gradient (Figure 4B), whereas the main Golgi
apparatus/endosomal signals were recovered in fractions
8–9. This observation suggests that Sit1-GFP was not
strictly restricted to a ‘pure’ Golgi–endosomal pool. Instead,
it may form two different pools: a major endosomal pool
and a small plasma membrane pool resulting in a small
shift of the main signal on the gradient (Figure 4B).
After 1 h of synthesis in the presence of FOB, Sit1-GFP
fluorescence was observed mostly at the plasma mem-
brane, with some intracellular dots (Figure 4A). Accord-
ingly, immunodetected Sit1-GFP was mostly colocalized
with the plasma membrane marker Pma1 on sucrose
gradients. Some free GFP was also detected, correspond-
ing to a small fraction directly targeted to the Vps/vacuolar
pathway or protein subjected to endocytosis (Figure 4B).
Thus, Sit1-GFP was mainly sorted to the endosomal/
vacuolar pathway when synthesized in the absence of
substrate, and mainly targeted to the plasma membrane
when synthesized in the presence of substrate. We then
Figure 4: FOB-dependent localization of Sit1-GFP. The sit1D
cells transformed with pGAL-SIT1-GFP were cultured overnight in
raffinose-containing medium. Sit1-GFP synthesis was induced for
1 h by adding galactose to the medium with (þFOB) or without
( FOB) 10 mM FOB. A) Cells were visualized by fluorescence
microscopy with a GFP filter set and B) processed for subcellular
fractionation. Cells were lysed and protein extracts were fraction-
ated on a 20–60% sucrose density gradient. Aliquots of the various
fractions were analysed by Western immunoblotting for the pres-
enceofGFP,PGK(acytosolicprotein),plasmamembraneATPase1
(Pma1), Vps10 (carboxypeptidase Y receptor, which cycles
between the Golgi and late endosome compartments), Pep12
(SNARE protein involved in the fusion of vesicles with late endo-
somes),Vps55(transmembraneprotein ofthelateendosomes) and
Vph1 (transmembrane subunit of the vacuolar ATPase).
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partments could subsequently be targeted to the plasma
membrane after the addition of FOB or other siderophores.
Experiments were performed on sit1D cells transformed
with the pGAL-SIT1-GFP construct and grown overnighton
a raffinose-based medium. The cells were incubated with
galactose for 60 min for induction. Glucose was added and
incubated with the medium for 10–15 min to stop trans-
porter synthesis and a siderophore was then added. The
location of the siderophore transporter was determined by
assessing fluorescence 30 min after addition of the side-
rophore, whereas the rate of siderophore transport by the
washed cells was measured in parallel experiments. Ob-
servations of GFP fluorescence showed that Sit1 was
sorted to endosomes and vacuoles after the transient ex-
pression of SIT1-GFP (Figure 4A, left panel and Figure 5A,
panel 1), but rapid, massive translocation to the plasma
membrane was observed if the cells were briefly exposed
to FOB, the principal substrate of Sit1 (Figure 5A, panels 2
and 3). Plasma membrane sorting from internal compart-
ments was also observed when protein synthesis was
inhibited by incubation with cycloheximide for 5 or 15 min
before the addition of external FOB. Thus, the external
substrate clearly alters the fate of presynthesized Sit1
(Figure S4). The movement of Sit1 to the plasma mem-
brane was accompanied by an increase in the ability of
cells to take up FOB (Figure 5B). The gallium analog of
FOB [Ga-desferrioxamine (DFOB)] also promoted the
movement of Sit1 to the plasma membrane (Figure 5A,
panels 4 and 5), although less effectively than FOB itself.
The presence of a strong GFP signal in the vacuole lumen
indicated that a large proportion of the Sit1 present
reached the vacuole for degradation. This effect was
observed to a much lesser extent when FOB was the
inducer (Figure 5A, panels 2 and 3). Thus, Ga-DFOB was
also less effective than FOB at promoting FOB uptake by
the washed cells (Figure 5B). Exposure of the cells to two
other substrates of Sit1 – FCH and FC – also resulted in the
rapid translocation of the protein to the plasma membrane
(Figure 5A, panels 6 and 7). Remarkably, CG, which is not
a substrate of Sit1 (see below), had the same effect
(Figure 5A, panel 8), whereas ENB and TAF had no effect
on the distribution of Sit1 (Figure 5A, panels 9 and 10).
Other sources of iron, such as ferric citrate and hemin,
were also unable to promote the plasma membrane
targeting of Sit1 (Figure 5A, panels 11 and 12). The uptake
of FOB by the cells was increased in all cases by prior
incubation of the cells with a siderophore, promoting the
movement of Sit1 to the plasma membrane (Figure 5B).
Thus, FOB, FC, FCH and CG all caused Sit1 to move rapidly
from internal compartments to the plasma membrane, and
this effect occurred at all siderophore concentrations
tested (within the range 1–100 mM). Thus, brief exposure
of the cells to a siderophore (CG) that is not a substrate of
a given transport system (Sit1) may induce this transport
system by promoting plasma membrane sorting. This
mechanism may have an important adaptive function
for cells.
The same experiments were conducted with Enb1-GFP.
Galactose induction resulted in the immediate movement
of the protein to the plasma membrane (see Figure 3). The
kinetics of Enb1 targeting to the plasma membrane were
unaffected by the experimental conditions tested (with or
without various siderophores in the growth medium; data
notshown).Thus,thesetwosiderophoretransportershave
very different patterns of intracellular trafficking, one with
and the other without substrate-induced regulation.
Fate of Sit1 in wild-type and mutant strains
showing high levels of FOB uptake
In a previous study, we showed that several mutants of
S. cerevisiae deficient in various steps of protein trafficking
had a phenotype of high FOB uptake (31). This was notably
the case for mutants defective in various stages of Golgi-
to-vacuole targeting – Golgi sorting (gga2D, arf1D) – or late
endosome maturation to multivesicular bodies (MVB)
(several vps class E mutants). We compared the intracel-
lular fate of Sit1-GFP in wild-type and sit1D cells, and in one
mutant of each of these classes (gga2D, vps28D) trans-
formed with pGAL-SIT1-GFP.
Table 1: Effect of ENB1-GFP and SIT1-GFP overexpression on the uptake of various iron sources
Strain WT ENB1-GFP SIT1-GFP
Iron source
FOB 2.99   0.49 4.39   0.56 220.56   13.43
ENB 18.54   1.15 35.48   1.39 12.23   1.15
FCH 31.44   1.12 32.21   1.65 120.18   11.20
FC 32.88   1.48 31.84   4.2 114.51   4.69
CG 4.19   0.14 3.81   0.35 3.4   0.27
TAF 7.55   0.74 8.04   0.32 5.28   0.34
Fe
3þ (citrate) 14.27   0.85 16.33   0.46 11.03   2.13
Wild-type (WT) cells, Enb1D cells transformed with pGAL-ENB1-GFP (ENB1-GFP) and sit1D cells transformed with pGAL-SIT1-GFP (SIT1-
GFP) were grown overnight in galactose-defined medium, diluted 1:10 in the same medium and grown for a further 5 h. We added 1 mM
55Fe (as various iron chelates) and determined the amount of iron taken up by the cells (in pmol/A600) after 40 min. The results are
expressed as means   standard error of the mean for three experiments.
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and incubation for 30 min with (þFOB) or without ( FOB)
substrate, the steady-state location of Sit1 varied accord-
ing to the strain examined (Figure 6). As described above,
in wild-type and sit1D cells, Sit1-GFP was targeted to
endosomes and the vacuolar lumen in the absence of FOB
(Figure 6,  FOB) and was targeted to the plasma mem-
brane in the presence of FOB (Figure 6, þFOB). In the
vps28D mutant, Sit1-GFP accumulated in large juxtava-
cuolar structures, the class E compartment, and at the
vacuolar membrane. The cells also displayed faint plasma
membrane staining (Figure 6,  FOB). Plasma membrane
staining in the presence of FOB was clearly stronger than
that in wild-type cells (Figure 6, þFOB). This observation is
consistent with the higher level of FOB uptake observed in
these mutant cells (31) and, more generally, with the larger
Figure 5: Siderophore-induced relocation of Sit1-GFP. The Sit1D cells transformed with pGAL-SIT1-GFP were cultured to
midexponential growth phase in raffinose-containing medium. Sit1-GFP synthesis was induced by incubation with galactose for 60 min
and was stopped by adding glucose and incubating for 15 min. The sorting of Sit1-GFP from the endosomes to the plasma membrane was
assessed A) by fluorescence microscopy and B) by measuring FOB uptake after incubation with the indicated compound for 30 min. For
uptake experiments, the cells were rapidly washed with water and filtered before resuspension in minimal glucose medium containing
1 mM
55Fe-FOB. The iron content of the cells was determined after 10 min of incubation at 308C. Uptake values (B) are expressed as
means   standard error of the mean for three experiments.
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the steady state reported for various class E mutants,
including vps28D (32,33). These properties are clearly
explained by the sorting defect in these mutants. In
vps28D cells, maturation of the late endosome is com-
promised and membrane proteins, such as transporters
coming from the Golgi compartment or subjected to
endocytosis from the plasma membrane, remain at the
limiting membrane of a large MVB (known as the class E
compartment), rather than being sorted to the internal
vesicles of the MVB. This MVB sorting defect leads to the
endosome-to-plasma membrane targeting of these pro-
teins (32,34) and to an increase in their steady-state levels
at the plasma membrane.
A completely different situation was observed following
the production of Sit1-GFP in gga2D cells. Gga2 is an
adaptor protein involved in the Golgi-to-vacuole transport
of specific protein substrates (35). We have shown that
gga2D mutant cells have two marked phenotypes in terms
of iron metabolism (31): high FOB uptake and the intracel-
lular accumulation of nondissociated FOB. Interestingly,
whatever the experimental procedure ( FOB or þFOB),
Sit1-GFP was targeted directly to the plasma membrane
(Figure 6). Thus, Sit1 is a cargo displaying Gga2-dependent
Golgi-to-vacuole targeting. The steady-state distribution of
Sit1 at the plasma membrane in gga2D cells did not
prevent the cells from taking up FOB very efficiently (31).
This result suggests that FOB is translocated through Sit1
when the transporter is located at the plasma membrane –
as would be expected for a ‘classical’ permease – rather
than after endocytosis of the transporter, as initially pro-
posed for Arn1 by Kim et al. (20).
Compartmentalization of intracellular FOB and
FOB-NBD in wild-type and mutant cells
We investigated the intracellular fate of internalized FOB in
S. cerevisiae, using the NBD fluorescent derivative of FOB
(36). We first checked that the cells used the fluorescent
derivative of FOB in the same way as native FOB.
Desferrioxamine (DFOB)-NBD (7-nitrobenz-2-oxa-1,3-diaz-
ole-(D)FOB) (1 mM) fully restored the growth of
a fet3Dfet4D strain cultured on minimal (YNB) medium,
as did DFOB (1 mM). After 2 days of incubation in liquid
YNB–glucose medium, the fet3Dfet4D strain had a cell
density only 5% that of the wild-type strain, and normal
growth was entirely restored when 1 mM DFOB-NBD or
DFOB was added to the medium (data not shown). Thus,
DFOB-NBD makes iron present in the medium available to
cells deficient in reductive iron uptake. Moreover, both
FOB and FOB-NBD, unlike CG, restored the growth of
a wild-type strain, but not of a sit1D strain plated on
complete agar medium containing a large excess (1 mM)
of bathophenanthroline disulfonic acid (BPS) (which pre-
vents reductive iron uptake by the cells; Figure 7). Thus,
FOB-NBD is used as an iron source in a Sit1-dependent
manner, as is native FOB.
We analysed the intracellular fate of internalized FOB in
wild-type andmutantcellsusingthegallium analogofFOB-
NBD rather than ferric FOB-NBD because Ga(III) does not
quench the fluorescence of the complex, whereas Fe(III)
does.ThefluorescentsignalobtainedwiththeGa(III)analog
of FOB-NBD was systematically stronger than that ob-
tained with ferric FOB-NBD, although the intracellular
location of the fluorescence was the same (data not
shown). We also checked that the cells took up the
Figure 6: Sit1-GFP location in
wild-type (WT) and mutant cells.
Wild-type and mutant cells, trans-
formed with pGAL-SIT1-GFP, were
cultured overnight in raffinose-
containing medium to midexponential
growth phase. Sit1-GFP synthesis
was induced by incubating the cells
for 1 h with galactose. Glucose was
then added and the culture was
incubated for 15 min to stop galac-
tose induction, and GFP fluores-
cence was monitored either
immediately( FOB) or after a further
30-min incubation of the cells with
1 mM FOB (þFOB).
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below).Wild-typecellsgrowninthepresenceofthegallium
analog of FOB-NBD (10 mM) accumulated the fluorescent
probe in the vacuole (Figure 8A). No fluorescence was ob-
served in sit1D cells under the same conditions (Figure 8A),
indicating that Sit1 mediated the internalization of the
fluorescent siderophore analog, as expected. Sit1 was
not expected to reach the vacuole lumen in the vps28D
mutant (see Figure 6). Despite this defect, the fluorescent
FOB analog was again found within the vacuole (Figure
8A). Finally, the apparent constitutive location of Sit1 at
the plasma membrane in gga2D cells (see Figure 6) did not
prevent the fluorescent FOB analog from accumulating
in the vacuole (Figure 8). As FOB-NBD was found essen-
tially in the vacuolar lumen, we checked whether this
corresponded to the typical fate of native FOB. For this
Figure 8: Intracellular location of FOB-NBD in wild-type (WT) and mutant cells. A) Wild-type and mutant cells were cultured in
glucose-containing medium to midexponential growth phase and were then incubated in the presence of 10 mM Ga-DFOB-NBD for 3 h.
The cells were then washed with water and examined for Ga-DFOB-NBD fluorescence using the GFP filter set and with Nomarski optics.
B) The sit1D cells transformed with pGAL-SIT1-GFP were grown overnight in galactose-defined medium supplemented with 100 mM FOB.
The whole organellar fraction was collected after protoplast lysis by moderate osmotic shock (Materials and Methods). Intact organelles
were separated on a discontinuous Ficoll gradient and collected as nine separate fractions. The absorbance of each fraction was measured
at420 nm(maximumabsorbanceofFOB)aftersolubilizationwith0.1%SDS.Thefractionswereanalysed byWesternblottingwithananti-
Vph1 (vacuolar marker) and an anti-GFP antibody (free GFP only, corresponding to the cleaved form of Sit1-GFP, present in the vacuolar
fractions).
Figure 7: Sit1-dependent use of
FOB-NBD by the cells. Wild-type
(WT) or sit1D cells were plated on
YPD-agar medium supplemented
with 1 mM BPS (to prevent reduc-
tive iron uptake). Sterile filter paper
disks containing siderophores (5 mL
of 10 mM CG, FOB or FOB-NBD)
were placed on the surface of the
agar. Plates were incubated for
2 days at 308C and photographed.
Growing cells appeared as a white
halo around the filter papers.
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spectrophotometric detection of FOB in the subcellular
fractions. Cells transformed with the pGAL-SIT1-GFP plas-
midwereincubatedovernightwithgalactoseinthepresence
ofFOB.VacuoleswerepreparedfromprotoplastsonaFicoll
gradient. Ferrioxamine B-derived visible light absorption and
Sit1-GFP-derived free GFP were detected in fractions 1–3,
which were enriched in the membrane-bound vacuolar
marker Vph1 (Figure 8B). Native FOB was therefore sorted
to the vacuoles. Thus, the distribution of Ga-DFOB-NBD
reflects the intracellular distribution of the siderophore and
canbeusedasaconvenientandrapidmethodformonitoring
the intracellular fate of siderophores.
Our observations clearly indicate that the siderophore
transporter (Sit1) and the siderophore itself (FOB) do not
follow the same intracellular routes. In this particular case
(Sit1/FOB), the fate of the transporter and that of the
siderophore may be dissociated early in the process of
siderophore uptake. This hypothesis requires confirmation
by further experiments, but our data clearly suggest that
intracellular FOB isstored in the vacuole, whatever the fate
of the FOB transporter. This conclusion is further sup-
ported by the experiments using FOB-AF (acifluorfen-(D)
FOB) described below.
Compartmentalization of imported FOB-AF
Acifluorfen is a powerful inhibitor of protoporphyrinogen
oxidase, a mitochondrial enzyme catalysing the formation
of protoporphyrin IX from protoporphyrinogen in the heme
biosynthetic pathway. We covalently coupled this inhibitor
to DFOB, using the same chemical coupling procedure
as for Ga-DFOB-NBD (Methods) and assessed the inhibi-
tory effect of (D)FOB-AF with respect to AF on protopor-
phyrinogen oxidase activity in vitro. The siderophore drug
conjugate displayed weaker inhibitory activity than AF
alone (Figure 9A), particularly when iron was bound to
the siderophore moiety. This was probably because of
steric constraints, as the substrate-binding domain (which
is also the inhibitor-binding domain) of protoporphyrinogen
oxidase encompasses a narrow active site cavity (37).
Despite this limitation, the IC50 values measured with
DFOB-AF and FOB-AF were nonetheless low enough
(about 10
 7
M and 10
 6
M, respectively; Figure 9A) for
the drug conjugates to be used as potent inhibitors of
heme synthesis in yeast. Nevertheless, although AF-
methyl efficiently inhibited S. cerevisiae growth on agar
plates, the siderophore drug conjugate did not (Figure 9B).
We then checked whether the cells took up FOB-AF
efficiently. Both the fluorescent analog of FOB (FOB-
NBD) and the siderophore drug conjugate (FOB-AF) were
taken up by the cells through Sit1, although less efficiently
than FOB itself (Figure 9C). We cultured cells bearing the
SIT1 gene under control of the GAL1 promoter with
galactose as the carbon source and in the presence of
FOB-AF or FOB (100 mM). The washed pellets of cells
cultured overnight in these conditions were brownish
yellow in colour (the colour of undissociated siderophore),
indicating that they had accumulated large amounts of
FOB/FOB-AF (data not shown). The cells grown with
FOB-AF showed no growth defect (and no porphyrin
accumulation), like those grown with FOB (data not
shown). However, when these cells were disrupted with
glass beads, the protoporphyrinogen oxidase activity mea-
sured in vitro on cell extracts was completely inhibited in
cells grown with FOB-AF (Figure 9D). Thus, protoporphyri-
nogen oxidase activity was not inhibited in vivo in cells that
had accumulated enough siderophore drug conjugate to
inhibit the enzyme fully in vitro, despite considerable
dilution of the inhibitor (by about 1:1000) because of cell dis-
ruptioninsuspensionbuffer.Themostprobableexplanation
is that the drug was strictly compartmentalized in vivo,
such that it could not reach its mitochondrial target unless
the cells were completely disrupted. This observation,
together with the fluorescence microscopy observations
obtained with FOB-NBD, strongly supports the hypothesis
that FOB is tightly compartmentalized in the vacuole after
its uptake by the cells. It also shows the intrinsic limitation
of coupling a drug to a siderophore to generate new
antifungal compounds. In this case, FOB-AF cannot be
used as an antifungal agent against S. cerevisiae, contrary
to our expectations.
Discussion
Our understanding of the mechanisms involved in side-
rophore transport in yeast has considerably improved over
the last few years. One of the most interesting findings to
emerge from the study of Arn1 is that this transporter is
targeted from the endosome to the plasma membrane,
and that this sorting is induced by the substrate of the
transporter, FCH, acting on the single extracytosolic
C-terminal loop of the protein (19,20). We investigated, in
this study, the possibility that this is a property common to
other siderophore transporters.
We investigated the intracellular fate of siderophore trans-
porters, using GFP fusion proteins and focusing principally
on Sit1 and Enb1 rather than Arn1 and Taf1. Direct
fluorescence observations are potentially more sensitive
than the indirect immunofluorescence methods used in
most studies of Arn1 trafficking, but there is a risk that the
GFP tag might alter the behaviour of the fused proteins.
We checked that the cells producing GFP transporter
fusions took up siderophores in the same way as cells
expressing untagged transporters. We used the strong
GAL1 promoter, which can be regulated, to monitor the
intracellular fate of transporters, particularly in the pres-
ence andabsence of substrates, without interference from
transcriptional effects. The use of a strong heterologous
promoter may generate problems with interpretation, as
protein overproduction may lead to mislocalization, but we
checked that the amount of protein produced under our
experimental conditions (short induction times) did not
exceed that with native promoters under inducing
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the limitations mentioned above, the main conclusions of
our work are as follows. As described for Arn1 (19), the
newly synthesized Sit1 protein initially accumulated in
endosomal compartments. In contrast, Enb1 protein was
directly targeted to the plasma membrane. Direct target-
ing to the plasma membrane of the FCH transporter of C.
albicans (CaSit1/CaArn1) has already been suggested in
another study (23) in which the authors demonstrated the
plasma membrane location of CaSit1/CaArn1 expressed
under the control of its own promoter. We obtained
similar results with the transient induction of GFP-tagged
CaSit1/CaArn1 placed under the control of the GAL pro-
moter and reinserted in two copies at the CaARN1 locus
(Figure S5). Thus, our work shows that different side-
rophore transporters behave differently in terms of intra-
cellular trafficking.
We found that both Arn1 and Sit1, although mainly present
in endosomal compartments, were also targeted to the
plasma membrane, to some extent, after expression of the
corresponding genes under the control of their native
promoters and growth of the cells in the absence of
substrate, in iron-deficient conditions. The massive target-
ing to the plasma membrane of Arn1 and Sit1 from internal
compartments was promoted by the addition of side-
rophores to the medium. However, in contrast to what
has been observed for Arn1 (19), we found that the plasma
membrane sorting of Sit1 was triggered not only by its
specific substrate but also by a siderophore (CG) that is not
a substrate of this transporter. This suggests that the
sensing domain of the protein may not have the same
specificity as the transporting domain, although this point
remains to be investigated. All the same, our observations
show that it is not necessary to postulate that the
Figure 9: The AF-FOB conjugate does not reach its target in vivo. A) The IC50 values of free AF (s), DFOB-AF (d) and FOB-AF (j) for
protopor. oxidase activity were determined in vitro on whole cell extracts. B) Wild-type S. cerevisiae cells were plated as a lawn on YPGly
agar. Wells were created in the agar with a hole punch, into which 50 mLo f1m M FOB-AF or 25 mL FOB 2 mM þ 25 mLA F2m M was
dispensed. Cell growth on the plate was examined after 3 days at 30 seconds. It was inhibited only with FOB þ AF (inhibition visible as
a halo around the bottom well). C) Accumulation of FOB and FOB conjugates in cells overexpressing SIT1. Sit1D cells transformed with
pGAL-SIT1-GFP were cultured overnight in raffinose-containing medium to midexponential growth phase. We then added glucose (2%) or
galactose (2%) and cultured the cells for a further 4 h.
55Fe-labelled FOB, FOB-NBD or FOB-AF was then added, and the amount of
55Fe
accumulated by the cells was determined after 15 min of incubation. Results are expressed as means   standard error of the mean for six
experiments. D) Accumulated FOB-AF inhibits protopor. oxidase in vitro. Sit1D cells transformed with pGAL-SIT1-GFP were cultured
overnight in galactose-containing medium in the presence of 100 mM FOB (u) or 100 mM FOB-AF (j). The cells were then washed and
disrupted with glass beads. The activity of protopor. oxidase was determined on whole cell extracts at various protein concentrations.
Protopor., protoporphyrinogen.
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through a Sit1-independent pathway, before the trans-
porter moves to the plasma membrane. The signal for
movement may be sensed at the plasma membrane itself,
perhaps through a special high-affinity receptor domain of
Sit1 similar to that of Arn1 (20). This may require the
presence of small amounts of transporter at the plasma
membrane (as observed by fluorescence analysis and
sucrose gradient fractionation) even if the transporter is
synthesized in the absence of any substrate – for both
chromosome-encoded (stable expression) and plasmid-
encoded (transient expression) transporters. In contrast
to what has been reported for Arn1 and Sit1, we found no
evidence of a siderophore-sensing mechanism for Enb1.
The transport of different siderophores may involve differ-
ent uptake mechanisms. Further work is now required to
determine exactly how siderophores are transported by
the various siderophore transporters of yeast. We also
need to determine why structurally similar siderophore
transporters may function very differently. The construc-
tion of hybrid proteins (e.g. various domains of Arn1 and/or
Sit1 fused to other domains of Enb1) should open up new
and informative avenues of investigation.
The localization of Sit1-GFP in the presence or absence of
FOB in various trafficking mutants provides an explanation
for the high FOB uptake phenotype previously observed in
many mutants with impaired intracellular protein trafficking
(31). Indeed, in cells deficient for MVB sorting (vps28),
higher than normal levels of Sit1-GFP accumulation at the
plasma membrane were observed, even after growth in
the absence of FOB, probably because of enhanced
endosome-to-plasma membrane sorting, as previously
reported for other plasma membrane transporters in vps
class E mutants (32,33). More strikingly, gga2D cells,
deficient in the clathrin adapterGga2 andpreviously shown
to display a high level of FOB uptake (31) displayed
identical plasma membrane sorting of newly synthesized
Sit1-GFP in both the presence and the absence of FOB –
Sit1 was therefore not sorted from the Golgi compartment
directly to vacuoles in the absence of FOB, as observed in
wild-type cells. The siderophore transporter Arn1 has been
shown to display partial sorting to the plasma membrane in
gga2D cells, even when synthesized in the absence of its
substrate (FCH), under conditions in which wild-type cells
display exclusively vacuolar sorting (38). These two side-
rophore transporters thus extend the list of cargoes dis-
playing Gga2-dependent sorting to the Vps pathway.
We also considered the fate of internalized siderophores
(FOB). Internalized FOB undergoes rapid intracellular com-
partmentalization, as shown by the failure of a FOB drug
conjugate (FOB-AF) to reach its mitochondrial target in vivo.
The observation that siderophores (or at least FOB and
FOB conjugates) undergo strict intracellular compartmen-
talization has major negative implications for the design of
new antifungal drugs based on the Trojan Horse approach.
Bernier et al. (39) have already reported much lower levels
of activity against different Candida species for desketo-
neoenactin-siderophore conjugates than for the unconju-
gated drug, despite the uptake of the siderophore drug
conjugate by cells. They suggested that it might be
necessary to release the drug from the conjugate for
optimal interaction with the drug target (39). Our study
confirms the inefficiency of the Trojan Horse approach and
provides an explanation for this observation.
Ferrioxamine B is probably compartmentalized to the vacu-
ole, as deduced from two complementary approaches. We
checked that a fluorescent derivative of FOB, FOB-NBD, is
used as an iron source in a Sit1-dependent manner.
Ferrioxamine B-NBD (or its gallium analog, which displays
enhanced fluorescence) was observed to accumulate in
the vacuolar lumen of wild-type cells in a Sit1-dependent
way. The fate of the fluorescent FOB derivative probably
reflects the fate of native FOB: we observed the recovery
of native FOB, detectedspectrophotometrically, inisolated
intact vacuoles prepared from wild-type cells containing
Sit1, after gentle protoplast lysis and fractionation on
a Ficoll gradient. Conversely, it has been suggested that
FCH accumulates in the cytosol, and not in organelles,
after its uptake (17). However, these authors fractionated
protoplasts by differential centrifugation, which might
disrupt vacuoles. The vacuolar accumulation of FOB may
be Aft1 dependent, as we previously observed the prefer-
ential accumulation of FOB in the late endosome in an
AFT1
up strain overaccumulating undissociated FOB (30).
Perhaps, the intracellular fate (storage and dissociation) of
siderophores differs according to the particular sidero-
phore taken up by the cell, as does the mechanism of
transport. The structure of ENB (catecholate-type side-
rophore) is very different from that of FOB (hydroxamate-
type siderophore), and it is therefore not unreasonable to
assume that these two siderophores might be processed
differently by the cell.
As FOB-NBD mimicked the fate of native FOB, and could
therefore be considered a powerful and easy-to-use probe,
we used it to monitor the intracellular fate of FOB in sev-
eral trafficking mutants shown to have high levels of FOB
uptake in our previous genomic study (39). These mutants
displayed enhanced plasma membrane accumulation of
Sit1-GFP. Ferrioxamine B-NBD (or its gallium analog) was
recovered in the vacuolar lumen of wild-type cells and of
vps28D cells in which Sit1-GFP is located at the plasma
membrane and in the class E compartment. Strikingly,
gga2D cells, which have high levels of FOB uptake and in
which Sit1-GFP is located exclusively at the plasma mem-
brane,displayedstrong vacuolaraccumulationofFOB-NBD.
The intracellular fate of the transporter (Sit1) therefore
appearstobelargelyindependentofthefateofitssubstrate
(FOB). These observations strongly suggest that Sit1 be-
haveslike a classicalpermease,withFOBbeing takenupby
the transporter at the plasma membrane. If, as shown here
for FOB, siderophores accumulate in the vacuole after
translocation through the transporter, we need to identify
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The vacuolar sorting of siderophores is consistent with the
notion that the acidic conditions in this organelle might
facilitate iron release from the siderophore.
Materials and Methods
Yeast strains and growth conditions
The S. cerevisiae strains used in this study are shown in Table 2.
Saccharomyces cerevisiae strains expressing chromosome-encoded GFP-
tagged siderophore transporters were grown at 308C in 2% glucose in
complete medium Yeast extract, bacto Peptone, D-glucose (YPD) supple-
mented with ferric citrate, BPS or various siderophores, as indicated in the
figure legends. Cells transformed with pGAL-ENB1-GFP (p416, ARS/CEN,
URA3, prom. GAL1) or pGAL-SIT1-GFP (p416, ARS/CEN, URA3, prom.
GAL1) were grown at 308C in minimal medium Yeast Nitrogen Base (YNB)
containing 0.67% yeast nitrogen base without amino acids (Difco) and
supplemented with the appropriate nutrients. The carbon source was 2%
glucose, or 2% galactose plus 0.02% glucose, as indicated in the figure
legends. Cells grown overnight in 2% raffinose plus 0.02% glucose to an
A600 nm of 0.5 were induced with 2% galactose, which was added to the
medium to induce synthesis of the siderophore transporter. Following the
addition of this sugar, the cells were incubated for further 60–90 min at
308C in the presence or absence of FOB, as indicated in the figure legends.
In cells used for studies on plasma membrane sorting, transporter
synthesis was stopped by adding 2% glucose to the medium. The cells
were then incubated for 30 min with the siderophore, at the concentrations
indicated in the figure legends.
The C. albicans strain used (CaArn1D::cat/CaArn1D::hisG, pABSK-GAL1-10-
CaARN1-GFP) was a gift from Dr Y. Wang (23) who constructed it from
the CAI4 wild-type strain.
Synthesis of DFOB conjugates
DFOB-NBD, the fluorescent derivative of DFOB was synthesized as pre-
viously described (40).
Chemical synthesis of AF-DFOB conjugate 1
The route followed for the synthesis of compound 1 is outlined in Figure 1.
Ligand 1 was obtained by a classic two-step procedure. Acifluorfen was
activated through DCC-mediated condensation with pentafluorophenol
to give the activated ester 2. This ester reacted with DFOB, in the
presence of triethylamine, in dimethyl formamide (DMF) to yield 1. All
reagents were of analytical grade and were dried and purified when
necessary. Thin-layer chromatography (TLC) analyses were carried out
on plates coated with silica or alumina gel 60 F254 (Merck). We used
60A silica gel with particles 6–35 or 40–63 mmi ns i z e( S D S )o rF l o r i s i l

100–200 mesh (ACROS) for column chomatography. Spectra were
obtained as follows:
1H NMR spectra were recorded at 500 MHz on
a Brucker AVANCE DRX 500. The MALDI-TOF-MS spectrum was
recorded on a Brucker BIFLEX III. Melting points were determined on
a Kofler bank and are uncorrected.
2,3,4,5,6-Pentafluorophenyl-5-(2-chloro-4-
trifluoromethylphenoxy)-2-nitrobenzoate (2)
A solution of 5-(2-chloro-4-trifluoromethylphenoxy)benzoic acid (Acifluofen)
(1.60 g, 4.44 mmol) in dry tetrahydrofuran (3 mL) was placed in a three-
necked round-bottomed flask under nitrogen. A solution of pentafluorophe-
nol (0.82 g, 4.44 mmol) and DCC (0.92 g, 4.44 mmol) in dry tetrahydrofuran
(7 mL) was added dropwise to the flask. The mixture was stirred under N2
at room temperature for 14 h. The resulting precipitate was removed by
filtration, and the filtrate was concentrated to dryness under reduced
pressure. The crude product was subjected to chromatography on a silica
gel column. Elution with methylene chloride–petroleum ether (80:20)
yielded a white solid identified as 2 (2.21 g, 94%). Melting point 106–
1088C.
1H NMR [500 MHz, dimethyl sulphoxide (DMSO)-d6]: d 7.12 [d.d
(doublet doublet), 1H, J ¼ 9 and 2.7 Hz], 7.30 [d (doublet), 1H, J ¼ 8.4 Hz],
7.35 (d, 1H, J ¼ 2.6 Hz), 7.65 (d.d, 1H, J ¼ 8.5 and 1.8 Hz), 7,84 (d, 1H,
J ¼ 1.8 Hz), 8.16 (d, 1H, J ¼ 9 Hz).
DFOB-AF (1)
Desferrioxamine mesylate salt (Desferal
) (700 mg, 1.06 mmol) and penta-
fluorophenyl ester 2 (728 mg, 1.38 mmol) were dissolved in DMF (18 mL)
and triethylamine (1.4 mL) under nitrogen. The reaction mixture was stirred
at 508C for 19 h. The solvent was removed under reduced pressure, and
the crude product was purified by column chromatography on silica gel,
with methylene chloride–methanol (95:5) as the eluent. The resulting
product was washed several times with ethyl acetate and then recrystal-
lized from methanol to yield 462 mg of conjugate DFOB-AF 1 (44%).
Melting point 170–1728C.
1H NMR (500 MHz, DMSO-d6): d 1.19–1.51 [m
(multiplet), 18H], 1.94 [s (singulet), 3H], 2.24 [t (triplet), 4H], J ¼ 7.2 Hz,
2.56 (t, 4H, J ¼ 6.8 Hz), 2.98 (m, 4H), 3.16 (t, 2H, J ¼ 6.6 Hz), 3.44 (t, 6H,
J ¼ 7 Hz), 7.19 (d.d, 1H, J ¼ 8.9 and 2.7 Hz), 7.22 (d, 1H, J ¼ 2.6 Hz), 7.48
(d, 1H, J ¼ 8.5 Hz), 7.77 (s, 2H), 7.83 (d.d, 1H, J ¼ 8.5 and 1.6 Hz), 8.09
(d, 1H, J ¼ 8.9 Hz), 8.14 (d, 1H, J ¼ 1.6 Hz), 9.60, 9.62 and 9.65 (3 s, 3H).
MS (MALDI-TOF): m/z 926 (MþNa)
þ, 942 (MþK)
þ.
Table 2: The S. cerevisiae strains used
Strain Relevant genotype Source
ARN1-GFP Mata leu2D met15D ura5D his5D ARN1-GFP::HIS3 Clontech
ENB1-GFP Mata leu2D met15D ura5D his5D ENB1-GFP::HIS3 This study
GFP-ENB1 Mata leu2D met15D ura5D his5D Gal-GFP-ENB1-::HIS3 This study
SIT1-GFP Mata leu2D met15D ura5D his5D SIT1-GFP::HIS3 Clontech
TAF1-GFP Mata leu2D met15D ura5D his5D TAF1-GFP::HIS3 This study
BY4741 (wild type) Mata leu2D met15D ura5D his3D Euroscarf
DEY1455 (wild type) Matalpha ade2 can1 his3 leu2 trp1 ura3 gal (48)
sit1D Mata leu2D met15D ura5D his5D sit1::kanMX Euroscarf
enb1D Mata leu2D met15D ura5D his5D enb1::kanMX Euroscarf
vps28D Mata leu2D met15D ura5D his5D vps28::kanMX Euroscarf
vam6D Mata leu2D met15D ura5D his5D vam6::kanMX Euroscarf
gga2D Mata leu2D met15D ura5D his5D gga2::kanMX Euroscarf
fet3Dfet4D Mata ade6 can1 his3 leu2 trp1 ura3 fet3-2::HIS3 fet4-1::LEU2 (48)
CHC-RFP Matalpha his3D1 leu2D0 lys2D0 ura3D0 YGL206C-RFP::kanMX6 (49)
SNF7-RFP Matalpha his3D1 leu2D0 lys2D0 ura3D0 YLR025W-RFP::kanMX6 (49)
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Yeast strains expressing GFP-tagged siderophore transporters were con-
structed by inserting the GFP coding sequence in frame with and at the
C-terminusoftheENB1 and TAF1 genes by homologous recombination (41).
ENB1 was also tagged with GFP at its N-terminus and placed under the
control of a GAL10 promoter, by the same method (41). The pGAL-ENB1-
GFP and pGAL-SIT1-GFP plasmids were obtained by inserting fragments
encoding ENB1 and SIT1, respectively, with a C-terminal GFP tag into the
p416-GALvector(42). These fragments were obtained bypolymerase chain
reaction, using genomic DNA from the chromosomal GFP-tagged strains as
templates.
Siderophore uptake
Coprogen and ENB were purchased from EMC Microcollection GmbH
(Germany). Desferri-FCH was purchased from Sigma. Desferrioxamine B
is the commercially available mesylate derivative, Desferal (Novartis).
Triacetylfusarinine was a gift from Dr H. Haas (Department of Molecular
Biology, Medical University of Innsbruck, Austria). The desferri-siderophores
wereloadedwith
55Fe (50 mCi/mg). Iron uptake was assayed inmicrotitration
plates (30). Unless otherwise stated, the cells were incubated for various
periods of time at 308Cw i t h1mM siderophore (final concentration), collected
with a cell harvester (Brandel) and washed on the filter with water.
Subcellular fractionation
Cell fractions were separated by gradient density centrifugation, essen-
tially as previously described by Kolling and Hollenberg (43). The growth of
exponentially growing cultures (after galactose induction, glucose stop-
ped, with or without FOB) was arrested by adding 10 mM sodium azide.
Cells were harvested by centrifugation, washed once in the presence of
10 mM sodium azide and disrupted by vortexing (four times, for 1 min
each) in the presence of glass beads and 0.5 mL of STE10 [10 mM Tris–
HCl buffer, pH 7.6 supplemented with 10% wt/wt sucrose, 10 mM
ethylenediaminetetraacetic acid (EDTA), 25 mM freshly prepared N-ethyl-
maleimide and protease inhibitors (Complete Cocktail, Roche)]. The
extract was transferred to a fresh tube and the beads were washed twice
with STE10. The extract and washings were pooled and centrifuged at
3000   g for 3 min to remove cell debris. An aliquot (750 mL) of the
cleared extract was layered onto a 11.1 mL 20–60% linear sucrose
gradient made up in Tris–HCl, pH 7.6 supplemented with 10 mM EDTA.
Samples were centrifuged for 18 h at 100 000   g in an SW41 rotor
(Beckman). We collected 0.8 mL fractions and precipitated the proteins in
these fractions by adding 0.8 mL of 20% trichloroacetic acid (TCA) and
incubating on ice for 60 min. Proteins were collected by centrifugation at
13 000   g for 45 min, resuspended in 10 mLo f1M Tris base þ 40 mLo f2  
sample buffer (44) and heated for 10 min at 378C.
Intact vacuoles were prepared on a discontinuous Ficoll gradient after lysis
of the protoplast suspension by moderate osmotic shock, as previously
described (45). All the proteins isolated by these fractionation methods
were analysed by Western blotting, as described below.
Yeast cell extracts, SDS–PAGE and Western
immunoblotting
Total protein extracts were prepared by the NaOH/TCA lysis technique (44).
Proteins were separated by SDS–PAGE, in gels containing 12% tricine, and
transferred to nitrocellulose membranes. The membranes were probed
with various antibodies, depending on the experiment: monoclonal anti-
bodies against GFP (Roche Diagnostics), Vph1p (Molecular Probes),
Vps10p (Molecular Probes), PGK (Molecular Probes) or polyclonal anti-
bodies against Pep12p (kindly provided by K. Bowers and T. Stevens) and
Pma1p (kindly provided by C. W. Slayman).
An antibody against the endosomal protein Vps55p was raised in rabbit (46).
A mixture of two synthetic peptides (in the second loop and the soluble
carboxy-terminus of the protein) was used to immunize two rabbits
(Eurogentec, Belgium).
Primary antibodies were detected with horseradish peroxidase-conjugated
anti-rabbit or anti-mouse immunoglobulin G secondary antibody (Sigma).
Secondary antibodies were detected with an enhanced chemilumines-
cence kit (ECL, Amersham).
Fluorescence microscopy
We used an Olympus BY61 microscope equipped with fluorescence and
Nomarski optics for our observations and a Spot charge-coupled device
camera (SPOT4.05) for image acquisition.
Green fluorescent protein fluorescence was monitored in cells collected
from the cultures and examined under the microscope with the fluores-
cein isothiocyanate (FITC) filter set either directly or after a single wash
with water.
For experiments investigating the colocalization of GFP staining with the
vacuolar lumen, cell cultures were incubated for 15 min with 5 mM 7-amino-
4-chloromethylcoumarin (CMAC) (Cell Tracker Blue, Molecular Probes). The
cells were collected and washed twice with water and were then examined
under the microscope for GFP staining and blue vacuolar staining
[6-diamidino-2-phenylindol-dihydrochlorid (DAPI) filter].
For yeast cell staining with the fluorescent analog of DFOB, DFOB-NBD
was loaded with equimolar concentrations of Fe(III) or Ga(III) salts to give
FOB-NBD or Ga-DFOB-NBD. Wild-type and mutant cells were cultured
overnight in glucose complete medium diluted to an A600 of 0.3–0.5 with
fresh glucose complete medium supplemented with 10 mM FOB-NBD or
Ga-DFOB-NBD. The culture was incubated for 3 h. The cells were then
washed twice with water and examined for fluorescence with the FITC
filter set and Nomarski optics.
Assays of growth in response to various iron sources
We investigated iron-dependent growth by plating cells as a lawn on YPD-
agar medium supplemented with 1 mM BPS (to prevent reductive iron
uptake). The cells were provided with various sources of iron in the form of
sterile filter paper disks containing siderophores (5 mLo f1 0mM CG, FOB or
FOB-NBD). Plates were incubated at 308C for 2 days and photographed.
ConjugatedAF toxicity to cellswasevaluatedbyplating wild-typeS.cerevisiae
cells asa lawn ona YPGly agar medium. We added50 mLo f1m M FOB-AF or
25 mLF O B2m M þ 25 mLA F2m M to wells made in the agar with a hole
punch. Cell growth on the plate was examined after 3 days at 308C.
Activity and inhibition of protoporphyrinogen oxidase
The activity of this enzyme was measured fluorimetrically as previously
described (47). IC50 values were determined with protoporphyrinogen
oxidase purified to homogeneity as previously described (47). Protopor-
phyrinogen oxidase inhibition by endogenous FOB-AF was assessed on
homogenates of cells disrupted with glass beads.
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Figure S1: Siderophore uptake by cells expressing native transporters
(WT) and by cells expressing chromosome-encoded GFP fusion trans-
porters (SIT1-GFP, ARN1-GFP, TAF1-GFP and ENB1-GFP). The indicated
strains were first cultured overnight in YPD medium. Cultures were then
diluted 1:10 in the same medium supplemented with 200 mM BPS and
incubated for 6 h. The cells were washed with water, resuspended in fresh
YPD medium and iron uptake was measured with 1 mM of FOB, FCH, TAF
or ENB. Results are expressed as the rate of uptake per A600 unit.
Means   standard error from three experiments are shown.
FigureS2:ComparisonofSit1-GFPlevels.Cells expressing chromosome-
encoded Sit1-GFP were cultured to midexponential growth phase in
complete medium (YPD). Sit1D cells bearing pGAL-SIT1-GFP were grown
to midexponential growth phase in raffinose-containing medium. Galactose
was then added to the medium and the cultures incubated for 1 or 2 h to
induce Sit1-GFP synthesis. Protein extracts were prepared from both
strains and analysed by Western blotting for GFP, using a monoclonal
anti-GFP antibody.
Figure S3: Colocalization of Sit1-GFP with CHC1-red fluorescent pro-
tein (RFP) and Snf7-RFP. CHC1-RFP (late Golgi marker) and SNF7-RFP
(late endosome marker) strains transformed with pGAL-SIT1-GFP were
grown overnight in raffinose-containing medium. Galactose was then
added and the culture incubated for 1 h to induce Sit1-GFP expression.
The distributions of Sit1-GFP, CHC1-RFP and Snf7-RFP were compared,
using the GFP and rhodamine filter sets. Arrows indicate colocalized
structures and arrowheads, structures that were not colocalized. Snf7-
RFP expression leads to the accumulation of a class E compartment (large
late endosome apposed to the vacuole) in which Sit1-GFP is trapped.
Figure S4:Siderophore-induced relocation of Sit1-GFP independent of
protein synthesis. The sit1D cells transformed with pGAL-SIT1-GFP were
cultured to midexponential growth phase in raffinose-containing medium.
Sit1-GFP synthesis was induced by incubation with galactose for 60 min.
Protein synthesis was blocked by adding cycloheximide (CHX, 10 mg/mL)
to the medium either together with galactose (pannel 1; control to ensure
that protein synthesis was immediately blocked with this concentration of
CHX) or after the galactose incubation period (panels 2 and 3). In the latter
case, cells were incubated with CHX for 5 min (panel 2) or 15 min (panel 3)
before adding FOB (1 mM) and incubating the cells for a further 15 min.
Sit1-GFP sorting was assessed by fluorescence microscopy, using the GFP
filter set.
Figure S5: Constitutive targeting of CaSit1/CaArn1 from C. albicans to
the plasma membrane. Cells with chromosomal GFP tags were cultured
to midexponential growth phase in raffinose minimal medium. CaSit1/
CaArn1-GFP synthesis was induced by incubation with galactose for
90 min. GFP fluorescence was assessed by fluorescence microscopy,
using the GFP filter set.
Supplemental materials are available as part of the online article at http://
www.blackwell-synergy.com
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